US EditionStat3 Inhibitor Extends Life of Cats with Head and Neck Cancer
Summary by scientias.nl
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Researchers have for the first time tested a new class of targeted cancer therapies in domestic cats with head and neck squamous cell carcinoma (HNSCC), a cancer that is notoriously fatal and difficult to treat. The therapy offers hope: in cats who responded, the average survival time after treatment was 161 days. When cat owner Tina Thomas learned from her veterinarian that her beloved Jak […] Want to know more about science? Read the latest ar…
·Middelharnis, Netherlands
Read Full ArticleCoverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
